doi: 10.1111/j.1748-720X.2011.00613.x.
The new era of comparative effectiveness: will public health end up left behind?
Affiliations
- PMID: 21871041
- DOI: 10.1111/j.1748-720X.2011.00613.x
Item in Clipboard
The new era of comparative effectiveness: will public health end up left behind?
J Law Med Ethics.
2011 Fall.
Abstract
The Patient Protection and Affordable Care Act created the nation's first comprehensive comparative effectiveness research (CER) program. According to some optimistic accounts, CER will revolutionize clinical practice and transform the health care delivery system. But what about public health? There are reasons for concern that it could end up left behind in the new era of comparative effectiveness. This article analyzes the considerable promise and serious limitations of applying CER to public health. It also highlights important issues that will likely emerge for public health law and policy as the health care system transitions to greater reliance on CER.
© 2011 American Society of Law, Medicine & Ethics, Inc.
Similar articles
-
The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.Pain Physician. 2011 May-Jun;14(3):E249-82. Pain Physician. 2011. PMID: 21587337 Review.
-
The implications of comparative effectiveness research for academic medicine.Acad Med. 2011 Jun;86(6):684-8. doi: 10.1097/ACM.0b013e318217e941. Acad Med. 2011. PMID: 21512362
-
Introduction: The prospects for public health reform.J Law Med Ethics. 2011 Fall;39(3):312-6. doi: 10.1111/j.1748-720X.2011.00601.x. J Law Med Ethics. 2011. PMID: 21871029 No abstract available.
-
Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.Pain Physician. 2010 Jan-Feb;13(1):E23-54. Pain Physician. 2010. PMID: 20119474 Review.
-
It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl A):S03-4. J Manag Care Pharm. 2011. PMID: 22074667